Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
نویسندگان
چکیده
diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8: 15. 8 Borgdorff MW, van der Werf MJ, de Haas PEW, et al. Tuberculosis elimination in the Netherlands. Emerg Infect Dis 2005; 11: 597–602. 9 Brinkmann B, Du Chesne A, Vennemann B. A survey of autopsy rates in Germany. Dtsch Med Wochenschr 2002; 127: 791–795. 10 Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J 2008; 31: 1256–1260.
منابع مشابه
Bronchiolitis obliterans following haematopoietic stem cell transplantation.
The aim of the present article is to review the available clinical data on bronchiolitis obliterans following haematopoietic stem cell transplantation (HSCT). The data sources used were the Medline database and references from the identified articles related to bronchiolitis obliterans, noninfectious pulmonary complications and HSCT. HSCT is an important treatment for a variety of malignant and...
متن کاملChanges in lung volumes and airway responsiveness following haematopoietic stem cell transplantation.
Changes in lung volume occur following haematopoietic stem cell transplantation (HSCT); airway hyperresponsiveness was occasionally reported, without mechanistic explanation. The present authors studied 17 patients by standard methacholine (MCh) challenge before and then 3 and 12 months after HSCT (n = 16 and n = 13, respectively). Another 6 patients were challenged before and 3 months after HS...
متن کاملLiving-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?
We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bronchiolitis obliterans (BO) is one of the late-onset noninfectious pulmonary complications that occur after allogeneic HSCT and is usually resistant to immunosuppressive therapy. A 17-year-o...
متن کاملCalcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Bronchiolitis obliterans is a complication after allogeneic haematopoietic stem cell transplantation (HSCT). Management of bronchiolitis obliterans comprises intensive immunosuppression, but treatment response is poor. We investigated the effect of cyclosporine A (CsA), tacrolimus (FK506), methylprednisolone (mPRED), mycophenolate mofetil (MMF) and everolimus on the proliferation of primary lun...
متن کاملObliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
A llogeneic and autologous haematopoietic stem cell (HSC) transplantation are now both established as principal forms of treatment for patients with acute or chronic leukaemia, aplastic anaemia and various immunodeficiency syndromes, as well as various nonhaematological malignancies and auto-immune disorders [1–3]. However, major limitations to the successful use of HSC transplantation include ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The European respiratory journal
دوره 38 2 شماره
صفحات -
تاریخ انتشار 2011